The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Glidipion

15 milligram(s) Tablet

Actavis Group PTC ehfEU/1/12/756/001-009

Main Information

Trade NameGlidipion
Active SubstancesPioglitazone hydrochloride
Strength15 milligram(s)
Dosage FormTablet
Licence HolderActavis Group PTC ehf
Licence NumberEU/1/12/756/001-009

Group Information

ATC CodeA10BG Thiazolidinediones
A10BG03 pioglitazone

Status

Authorised/WithdrawnAuthorised
Licence Issued15/03/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back